PRKAA2 and non-melanoma skin carcinoma: Taking into account situations where the same mutation had been reported in more than one case of melanoma or non-melanoma skin cancer, the overall frequency of mis-sense mutations in the AMPK-α2 sequence was 0.14 mutations/residue.